Abstract
Objective
The present study was undertaken to investigate the possible effects of various agents on thiopurine methyltransferase (TPMT) activity in red blood cells (RBCs) from patients with chronic inflammatory bowel disease (IBD).
Methods
In three groups of patients with very high, normal and intermediate TPMT activity (each n=6), the inhibitory potential of furosemide, piretanide, azathioprine (AZA) and testosterone was assessed by ex vivo measurements of TPMT activity in RBCs. From individual concentration–response curves, IC50 values have been determined.
Results
Independent of the basal TPMT activity, lowest IC50 values were calculated for furosemide (15–19 μM), followed by testosterone (30–72 μM), piretanide (300–313 μM) and AZA (430–532 μM). Compared with reported plasma concentration achieved during treatment, only furosemide would have the potential to inhibit TPMT also in vivo, whereas the IC50 values of the other agents are far above the corresponding plasma levels.
Conclusions
Our ex vivo study revealed that only furosemide has the potential to inhibit TPMT activity in patients with IBD. This possibility should be taken into consideration if the diuretic and AZA or 6-mercaptopurine are coadministered. However, the extrapolation to the clinical setting remains open.
Similar content being viewed by others
References
Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417–429
Lennard L (2002) TPMT in the treatment of Crohn’s disease with azathioprine. Gut 51:143–146
Schaeffeler E, Fischer C, Brockmeier D, Wernet D, Moerike K, Eichelbaum M, Zanger U, Schwab M (2004) Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 14:407–417
Egan LJ (2004) Drug interactions in gastroenterology: mechanisms, consequences, and how to avoid. Clin Gastroenterol Heptol 2:725–730
Szumlanski CL, Weinshilboum RM (1995) Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. Br J Clin Pharmacol 39:456–459
Xin HW, Fischer C, Schwab M, Klotz U (2005) Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease. Aliment Pharmacol Ther 21:1105–1109
Klemetsdal B, Straume B, Wist E, Aarbakke J (1993) Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. Eur J Clin Pharmacol 44:147–152
Lysaa RA, Giverhaug T, Wold HL, Aarbakke J (1996) Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide. Eur J Clin Pharmacol 49:393–396
Capdeville R, Mousson B, Bax G, Bertrand Y, Philippe N (1994) Interactions between 6-mercaptopurine therapy and thiopurine methyltransferase (TPMT) activity. Eur J Clin Pharmacol 46:385–386
Lennard L, Lilleyman JS, van Loon J, Weinshilboum RM (1990) Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet 336:225–229
McLeod HL, Relling MV, Liu Qing, Pui CH, Evans WE (1995) Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukaemia. Blood 85:1897–1902
Arenas M, Duley JA, Ansari A, Schobowale-Bakre EA, Fairbanks L, Soon SY, Sanderson J, Marinaki AM (2004) Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype. Nucleosides Nucleotides Nucleic Acids 23:1403–1405
Woodson LC, Maus TP, Reiter C, Weinshilboum RM (1981) Rat thiopurine methyltransferase: regulation by testosterone. J Pharmacol Experim Ther 218:734–738
Kröplin T, Weyer N, Gutsche S, Iven H (1998) Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 54:265–271
Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651–662
Bergan S, Rugstad HE, Klemetsdal B, Giverhaug T, Bentdal O, Sodal G, Hartmann A, Aarbakke J, Stokke O (1997) Possibilities for therapeutic drug monitoring or azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells. Ther Drug Monit 19:318–326
Van Meyel JJM, Gerlag PGG, Smits P, Russel FGM, Tan Y, Van Ginneken CAM, Gribnau FWJ (1992) Absorption of high dose furosemide (frusemide) in congestive heart failure. Clin Pharmacokinet 22:308–318
Ponto LLB, Schoenwald RD (1990) Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (part I). Clin Pharmacokinet 18:381–408
Ruf G, Gera S, Luus HG, Trenk D, de la Rey N, Loffler K, Schulz W, Jähnchen E (1994) Pharmacokinetics and pharmacodynamics of ramipril and piretanide administrated alone and in combination. Eur J Clin Pharmacol 46:545–550
Berg KJ, Walstad RA, Bergh K (1983) The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency. Br J Clin Pharmacol 15:347–353
Beermann B, Grind M (1987) Clinical pharmacokinetics of some newer diuretics. Clin Pharmacokinet 13:254–266
Chocair PR, Duley JA, Simmonds HA, Cameron JS (1992) The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 53:1051–1056
Lin SN, Jessup K, Floyd M, Wang TP, van Buren CT, Caprioli RM, Kahan BD (1980) Quantitation of plasma azathioprine and 6-mercaptopurine levels in renal transplant patients. Transplantation 29:290–294
McEvoy GK (ed) (2005) Azathioprine. AHFS drug information. American Society of Health System Pharmacists Inc, Bethesda, MD, pp 3654–3656
Elion GB, Bieber S, Hitchings GH (1954) The fate of 6-mercaptopurine in mice. Ann NY Acad Sci 60:297–303
Venkataramanan R, Habucky K, Burckart GJ, Ptachcinski RJ (1989) Clinical pharmacokinetics in organ transplant patients. Clin Pharmacokinet 16:134–161
Vermeulen A (1976) Plasma levels and secretion rate of steroids with anabolic activity in man. Environ Qual Saf Suppl:171–180
Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A (2004) Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525–533
Acknowledgements
The study was supported by the Robert Bosch Foundation, Stuttgart, Germany. The technical assistance of Mrs. M. Schick and the secretarial help of Mrs. H. Bonilla Torres are highly appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xin, HW., Fischer, C., Schwab, M. et al. Thiopurine S-methyltransferase as a target for drug interactions. Eur J Clin Pharmacol 61, 395–398 (2005). https://doi.org/10.1007/s00228-005-0950-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-005-0950-5